University of Rennes Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Rennes France (1885)

Organization Overview

First Clinical Trial
1999
NCT00151619
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

CHU de Pontchaillou - Rennes | CHU de Rennes (Rennes) | CHU Rennes | CHU RENNES | CHU Rennes,France | CHU Rennes, Hôpital Pontchaillou | CHU Rennes Pontchaillou | Hopital Pontchaillou | Hôpital Pontchaillou, 35033 Rennes | Hopital Pontchaillou Rennes | HOPITAL PONTCHAILLOU - RENNES CEDEX 9 | Institut NuMeCan, INRA 1341 | Institut NuMeCan, INRA 1341, INSERM 1241, Université de Rennes 1 | Pontchaillou Hospital | Professor of Clinical Neurology, Head of Neurology Department, Pontchaillou Hospital, Rennes, France | Rennes (FR), University College Hospital | Rennes University Hospital | RennesUniversity Hospital | Rennes University Hospital, Rennes, France | Rennes University Hospital - Service de cardiologie et maladies vasculaires | Service de parasito-mycologie - Rennes University Hospital | Service de Pharmacologie, CHU de Rennes 35 000 France ; Herve.allain@univ-rennes1.fr | University Hospital of Rennes